Diligence memo · auto-generated · as of July 2, 2026
Sangart Inc
Sangart Inc has raised $166M over 3 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Sangart Inc operates in Biotechnology, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sangart Inc has raised $166M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $101M on 2011-03-30.
Most recent recorded round closed around 2011-03-30.
Valuation (modeled)modeled
Provath models Sangart Inc at approximately $4.2B (range $457M–$9.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 3 months.
Last raise 15.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 95% of Biotechnology peers (4293 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: Micromet, Inc., BioMotiv, LLC, Arena Pharmaceuticals Inc.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.